The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
about
Molecular and clinicopathological findings in a tonsillar synovial sarcoma. A case study and review of the literatureSynovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors.Primary pleuropulmonary and mediastinal synovial sarcoma: a clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest ChinaExpression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcomaPrognostic value of SS18-SSX fusion type in synovial sarcoma; systematic review and meta-analysis.The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma.Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy.Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location.Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons.Prognostic factors and clinical outcomes in synovial sarcoma of the extremities.Enhancer of zeste homologue 2 (EZH2) expression in synovial sarcomas as a promising indicator of prognosis.SMARCB1-deficient Tumors of Childhood: A Practical Guide.The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials.Primary synovial sarcoma of the uterus.
P2860
Q34072080-A9A745DC-1511-4F41-8695-4252AC5B2596Q34622557-C8F20641-8145-4225-ABD7-040F12FBEB2DQ37082063-A6C3D230-A25B-4C30-ADFC-9E10E2913DE0Q37379626-02D2AABA-AC6E-4DA0-B513-98B6DA3A1471Q38555958-1E20DEE0-8BC1-4F0B-921A-5197215707A8Q38796815-482BCAD7-BBF0-4717-BFB4-08A151C2A4C8Q39233440-1AD3E4BB-A7EF-4E06-9160-ADED03C9DA7DQ39817880-18FA3360-D7E3-46DE-8DEF-3D89967558A7Q40738166-1C98596B-8193-4A8D-8532-AD55E50F6914Q43918357-32288B58-0639-4C68-A32D-63760DD9A666Q47158897-A355644E-E911-43E1-B33B-217CC8CA3665Q47894129-546322D8-DD1F-48D8-94A3-34ED8AF92349Q49051141-44E32A0E-8F14-45FF-BF03-EEA928D2182AQ51476109-283C3DCC-C178-4862-AAED-CF9356F6E4BF
P2860
The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The classic prognostic factors ...... sion type or ezrin expression.
@en
The classic prognostic factors ...... sion type or ezrin expression.
@nl
type
label
The classic prognostic factors ...... sion type or ezrin expression.
@en
The classic prognostic factors ...... sion type or ezrin expression.
@nl
prefLabel
The classic prognostic factors ...... sion type or ezrin expression.
@en
The classic prognostic factors ...... sion type or ezrin expression.
@nl
P2093
P1476
The classic prognostic factors ...... usion type or ezrin expression
@en
P2093
Esther Bastiaannet
Harald J Hoekstra
Suzan E ten Heuvel
P304
P356
10.1097/PAI.0B013E31818A6F5C
P577
2009-05-01T00:00:00Z